Mapmygenome, an AI-driven genomics and personalised health company based in Hyderabad, has acquired Microbiome Insights, a Canadian microbial sequencing player. This acquisition includes Microbiome Insights’ CAP-accredited Canadian laboratory and intellectual property. The deal enhances Mapmygenome’s scientific capabilities and facilitates its expansion into North America, aligning with its strategic growth plans and upcoming listing on the Indian stock exchanges. Post navigation JSW Steel flags risks from elevated Chinese exports, urges vigilance on imports from FTA nations Donald Trump’s trade policy thrown into turmoil! Will countries like India, China be tempted to hold off tariff talks?